Compare MCK & SBUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCK | SBUX |
|---|---|---|
| Founded | 1833 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.4B | 89.2B |
| IPO Year | N/A | 1992 |
| Metric | MCK | SBUX |
|---|---|---|
| Price | $819.05 | $88.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 23 |
| Target Price | ★ $882.69 | $97.87 |
| AVG Volume (30 Days) | 868.8K | ★ 9.5M |
| Earning Date | 02-04-2026 | 01-27-2026 |
| Dividend Yield | 0.40% | ★ 2.81% |
| EPS Growth | ★ 66.19 | N/A |
| EPS | ★ 32.12 | 1.63 |
| Revenue | ★ $387,094,000,000.00 | $37,184,400,000.00 |
| Revenue This Year | $14.87 | $4.86 |
| Revenue Next Year | $8.32 | $7.07 |
| P/E Ratio | ★ $25.54 | $54.19 |
| Revenue Growth | ★ 17.23 | 2.79 |
| 52 Week Low | $565.75 | $75.50 |
| 52 Week High | $895.58 | $117.46 |
| Indicator | MCK | SBUX |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 60.13 |
| Support Level | $801.21 | $84.50 |
| Resistance Level | $824.95 | $90.58 |
| Average True Range (ATR) | 16.74 | 1.96 |
| MACD | -2.27 | 0.40 |
| Stochastic Oscillator | 45.20 | 76.41 |
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Starbucks is one of the most widely recognized restaurant brands in the world, operating more than 40,000 stores across more than 80 countries at the end of March 2025. The firm operates in three segments: North America, international markets, and channel development (grocery and ready-to-drink beverage). The coffee chain generates revenue from company-operated stores, royalties, sales of equipment and products to license partners, ready-to-drink beverages, packaged coffee sales, and single-serve products.